Queen Mary University of London
London, United Kingdom
Purpose
to test the theory that a measured dose of vitamin A (retinoic acid) given with an oral vaccine will enhance immunoglobulin secretions in the gut, thus boosting the mucosal immune response. If successful, vitamin A could be used as an effective adjuvant for oral vaccines that target diarrhea, a leading cause of death among children worldwide.
Division
Global Health
Date
May 2012
Region Served
GLOBAL
Committed amount
$988,742
Grant topic
Discovery and Translational Sciences
Duration (months)
29
Grantee location
London, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.